Tariff revenue soars more than 300% as U.S. awaits Supreme Court decision

Tariff revenue soars more than 300% as U.S. awaits Supreme Court decision


A cargo ship is loading and unloading foreign trade containers at Qingdao Port in Qingdao, Shandong Province, China, Jan. 13, 2026.

Cfoto | Future Publishing | Getty Images

The U.S. government in January ran up a smaller deficit than a year ago, while tariff collections surged and provided a reminder of how pivotal a long-awaited Supreme Court decision could be to federal fiscal health.

Customs duties collected through tariffs totaled $30 billion for the month, putting the fiscal year-to-date tally at $124 billion, or 304% more than the same period in 2025.

President Donald Trump first levied the duties in April 2025 with an across-the-board rate on all goods and services entering the U.S. along with a menu of so-called reciprocal tariffs on individual countries. Since then, the White House has been negotiating with its trading partners, backing off on some of the more aggressive charges while maintaining tough talk on issues.

Last November, the Supreme Court heard oral arguments challenging the auspices under which Trump justified the tariffs. The decision was expected in January. The high court hasn’t ruled yet, and there’s concern in the White House that a negative ruling could force the U.S. into reimbursing the duties collected so far.

The tariffs helped put a dent in the pace of the budget deficit.

In the fourth month of the fiscal year, the shortfall totaled roughly $95 billion, down about 26% from the same period a year ago, the Treasury Department reported

Year to date, that put federal red ink at $697 billion, or down 17% from the same period of fiscal 2025, according to numbers not adjusted for calendar. Calendar adjustments put the deficit reduction at 21%.

Interest on the $38.6 trillion U.S. debt continues to be a burden on the national finances. Net interest paid totaled $76 billion for the month, more than all other expenditures except Medicare, Social Security and health care. Year to date, gross interest has totaled $426.5 billion, up from $392.2 billion the year before.



Source

Buying chip stocks is getting pricey. Traders don’t care
World

Buying chip stocks is getting pricey. Traders don’t care

Intel Xeon 6 processors are shown to CNBC at Intel’s advanced packaging facility in Chandler, Arizona, on November 17, 2025. Tony Puyol Semiconductors are a runaway train — up 17 of the past 18 sessions — and options traders are buying increasingly expensive call options to chase the rally higher. The VanEck Semiconductor ETF (SMH) […]

Read More
The charts are showing there’s more pain ahead for healthcare stocks, says Carter Worth
World

The charts are showing there’s more pain ahead for healthcare stocks, says Carter Worth

(Check out Carter’s worthcharting.com for actionable recommendations and live nightly videos.) The worst performing sector year to date is healthcare, and there is every indication there is more downside ahead. The 2-panel chart below tells the tale. The top panel is the Health Care Select Sector SPDR ETF (XLV) itself, and it is a bad […]

Read More
Intel’s stock soars more than 20% as chipmaker shows signs of a turnaround
World

Intel’s stock soars more than 20% as chipmaker shows signs of a turnaround

The Intel logo is displayed on a sign in front of Intel headquarters on Jan. 22, 2026 in Santa Clara, California. Justin Sullivan | Getty Images Intel shares soared more than 20% on Friday as investors cheered signs of renewed growth due to mounting artificial intelligence demand. The stock was up 22% as of early […]

Read More